BPA Call 36C25723A0030-36C25726N0476
Award Date 9/25/26
Potential Completion Date 9/24/27
Potential Value $1.5M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Brea, CA 92821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 10 issued a BPA call to Beckman Coulter, Inc. for immunochemistry cost-per-reportable-test services with a ceiling value of $1,276,876.10, awarded October 5, 2022. The call is issued under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule. Place of performance is Brea, California. The call is firm fixed price and runs through September 30, 2025. Beckman Coulter will deliver immunochemistry testing services on a...
- Veterans Integrated Service Network 22 issued a BPA call to Beckman Coulter, Inc. on September 1, 2026, with a ceiling value of $112,230.06 and an ultimate completion date of August 31, 2027. The call is firm fixed price and carries no set-aside. Place of performance is Brea, California. The source does not specify the parent BPA name, scope of delivery, or labor footprint for this call. Beckman Coulter's Division of US Customer Operations supplies automated clinical laboratory diagnostic...
- Veterans Integrated Service Network 10 issued a BPA call to Beckman Coulter, Inc. valued at $5.887 million for immunochemistry cost-per-reportable-tests services, with an award date of October 5, 2021 and ultimate completion date of October 4, 2022. The call was issued under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule. Work is performed in Brea, California. The call is priced on a firm fixed-price basis for immunochemistry diagnostic testing and associated reagents...
- Veterans Integrated Service Network 19 issued a BPA call to Beckman Coulter, Inc. for Chemistry & Immunochemistry cost-per-reportable-result services on August 1, 2026, with a ceiling value of $2,989,153.86 and an ultimate completion date of July 31, 2027. The call is placed under the GSA Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule. Performance occurs at Oklahoma City, Oklahoma. Beckman Coulter will deliver automated clinical laboratory diagnostic equipment, reagents,...
- Veterans Integrated Service Network 2 issued a BPA call to Beckman Coulter, Inc. for chemistry/immunochemistry cost-per-reportable-result services with a ceiling value of $464,943.18, awarded October 1, 2023. The call was issued under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule. Work is performed at the awardee's facility in Brea, California. The ultimate completion date is September 30, 2024. Pricing is firm fixed price on a cost-per-reportable-result basis for...
- Veterans Integrated Service Network 17 issued a BPA call to Beckman Coulter, Inc. for immunochemistry cost-per-reportable-result (CPRR) services at the South Texas Veterans Health Care System, with a ceiling value of $1,450,555.50 and an award date of September 25, 2025. The call is issued under a single-award blanket purchase agreement on a firm fixed-price basis. Place of performance is Brea, California. Work is scheduled for completion by September 24, 2026. The call requires delivery of...
- Veterans Integrated Service Network 17 issued a BPA call to Beckman Coulter, Inc. on June 1, 2025, with a ceiling value of $2,238,183.66 for chemistry and immunoassay automation line equipment and services, completing May 31, 2026. The call is issued under the GSA Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule. Place of performance is Brea, California. Beckman Coulter supplies automated clinical laboratory diagnostic equipment, reagents, consumables, and associated...
- Veterans Integrated Service Network 10 issued a BPA call to Beckman Coulter, Inc. with a ceiling value of $1,393,769.75 for immunochemistry cost-per-reportable-tests services, with an ultimate completion date of September 30, 2024 (award date October 1, 2023). The call was issued under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule on a firm fixed-price basis. Performance occurs in Brea, California. The requirement addresses decreasing left-over funding through...
- Veterans Integrated Service Network 10 issued a BPA call to Beckman Coulter, Inc. for immunochemistry cost-per-reportable-test services with a ceiling value of $6,584,953.64, with an award date of October 1, 2024 and ultimate completion date of September 30, 2025. The call is issued under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule. Work is performed in Brea, California. The contract is priced on a firm fixed price basis and covers immunochemistry testing under a...
- Veterans Integrated Service Network 21 issued a $204,189.05 delivery order to Beckman Coulter, Inc. on April 1, 2025, for chemistry and immunoassay cost-per-reportable-result (CPRR) services under a firm fixed-price arrangement. The order is ultimate completion date of September 30, 2025. Place of performance is Brea, California. Beckman Coulter is a clinical laboratory equipment and diagnostic services manufacturer headquartered in Brea, providing automated laboratory instrumentation and CPRR...
- 36C25723A0030Blanket Purchase Agreement
- 36C25723A0030-36C25726N0476BPA Call
Veterans Integrated Service Network 17 issued a BPA call to Beckman Coulter, Inc. for STX immunochemistry cost-per-reportable-result testing services on September 25, 2026, with a ceiling value of $1,450,555.50. Performance takes place in Brea, California. The call extends through September 24, 2027. No set-aside applies. Beckman Coulter delivers automated clinical laboratory diagnostic testing and associated reagents and consumables under this firm fixed price arrangement, operating as a manufacturer of clinical laboratory instrumentation and in-vitro diagnostic substances with capabilities in immunoassay, chemistry, urinalysis, hematology, and microbiology analysis.
Generated 8/13/26, 12:22 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5m | 8/11/26 |